The Latest Breaking News from Ambros

1 Penny Stock That Could Howl Its Way to the Top After a $150 Million Funding Boost

A merger and a $150 million capital infusion is giving Werewolf's next chapter more firepower, but investors still face risks.

Barchart · Aug 26

Little-Known HOWL Stock Skyrockets 100% on Biotech Merger News

Werewolf Therapeutics stock explodes higher on a merger agreement with Ambros Therapeutics. But is there any further upside left in HOWL shares?

Barchart · Aug 21